ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q2 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,521 | +566.9% | 140,499 | +469.5% | 0.02% | +700.0% |
| Q4 2023 | $528 | -27.5% | 24,672 | -39.1% | 0.00% | -57.1% |
| Q3 2023 | $728 | -59.6% | 40,539 | -54.2% | 0.01% | -53.3% |
| Q2 2023 | $1,802 | -38.2% | 88,585 | -33.9% | 0.02% | -37.5% |
| Q1 2023 | $2,917 | -1.2% | 134,042 | +40.7% | 0.02% | -44.2% |
| Q4 2022 | $2,952 | -99.7% | 95,258 | +162.8% | 0.04% | +258.3% |
| Q3 2022 | $925,000 | -57.7% | 36,241 | -66.3% | 0.01% | -55.6% |
| Q2 2022 | $2,185,000 | +14.0% | 107,624 | +39.0% | 0.03% | +12.5% |
| Q1 2022 | $1,916,000 | +830.1% | 77,446 | +919.2% | 0.02% | +700.0% |
| Q3 2021 | $206,000 | -76.4% | 7,599 | -77.4% | 0.00% | -70.0% |
| Q2 2021 | $873,000 | +323.8% | 33,679 | +141.4% | 0.01% | +150.0% |
| Q3 2020 | $206,000 | -68.1% | 13,949 | -51.7% | 0.00% | -76.5% |
| Q2 2020 | $646,000 | – | 28,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $91,347,000 | 18.37% |
| EcoR1 Capital, LLC | 7,521,024 | $261,356,000 | 8.33% |
| GREAT POINT PARTNERS LLC | 592,250 | $20,581,000 | 4.57% |
| FRAZIER MANAGEMENT LLC | 899,700 | $31,265,000 | 2.41% |
| Boxer Capital, LLC | 1,300,000 | $45,175,000 | 1.76% |
| Palo Alto Investors LP | 436,592 | $15,172,000 | 0.97% |
| Rock Springs Capital Management LP | 538,700 | $18,720,000 | 0.43% |
| Eversept Partners, LP | 182,612 | $6,345,767 | 0.40% |
| EAM Global Investors LLC | 58,683 | $2,039,000 | 0.36% |
| Woodline Partners LP | 609,981 | $21,197,000 | 0.30% |